Komori

Notice of Release of Video and Transcript of Briefing on Full-Year Results for the Fiscal Year Ending September 2026

Full year, FY ending Sep 2026Published 2026-11-18 09:30

Released the video and transcript of the briefing on full-year results for the fiscal year ending September 2026.

In short

  • Released the video of the briefing on full-year results for the fiscal year ending September 2026.
  • Released the transcript of the briefing on full-year results for the fiscal year ending September 2026.
  • Indicated a policy of continuing to provide information to help investors better understand the Company.

What decks usually leave out

COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deck

Margins and overheads

where each ¥100 of sales goes
Computed
a year ago9.7%now10.2%

Financial targets

the last five years against the target (green band), where one is stated
Computed
Return on equity5.7%
profit earned on shareholders' money
−0.8 pts on last year
4%10%16%FY22/9FY23/9FY24/9FY25/9FY26/9FY22/9: 7.9%FY23/9: 8.9%FY24/9: 14.2%FY25/9: 6.5%FY26/9: 5.7%5.7%
Return on equity
Period%
FY22/97.9
FY23/98.9
FY24/914.2
FY25/96.5
FY26/95.7
Equity ratio53.4%
how much of the balance sheet is owned outright
+3.2 pts on last year
45%50%55%FY22/9FY23/9FY24/9FY25/9FY26/9FY22/9: 47.4%FY23/9: 48.3%FY24/9: 50.6%FY25/9: 50.2%FY26/9: 53.4%53.4%
Equity ratio
Period%
FY22/947.4
FY23/948.3
FY24/950.6
FY25/950.2
FY26/953.4
Payout ratio46.8%
share of profit paid as dividends
+9.8 pts on last year
15%32%49%FY22/9FY23/9FY24/9FY25/9FY26/9FY22/9: 31.5%FY23/9: 26.2%FY24/9: 16.8%FY25/9: 37.0%FY26/9: 46.8%46.8%
Payout ratio
Period%
FY22/931.5
FY23/926.2
FY24/916.8
FY25/937.0
FY26/946.8

Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.

Not mentioned in this deck

18
Company KPIsBy businessWhat movedNew initiativesCapital spendingShare buybackDividendSelf-rating against planForecast assumptionsRisks priced into the forecastMid-term plan targetsA stated financial targetOrders and backlogPrice and volumeStore or site countHeadcountMarket size and shareInvestor Q&A
Notice of Release of Video and Transcript of Briefing on Full-Year Results for the Fiscal Year Ending September 2026 | Fuji Pharma Co.,Ltd. (4554) timely disclosure | Komori